{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:04:18Z","timestamp":1784988258289,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11655-026-3850-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:28:48Z","timestamp":1778650128000},"page":"675-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lianxia Xiaopi Granules for Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-Blind and Placebo-Controlled Trial"],"prefix":"10.1007","volume":"32","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-zhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-neng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3850_CR1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","volume":"396","author":"AC Ford","year":"2020","unstructured":"Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet 2020;396:1689\u2013702.","journal-title":"Lancet"},{"key":"3850_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of ROME foundation global study. Gastroenterology 2021;160:99\u2013114.","journal-title":"Gastroenterology"},{"key":"3850_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/2050640615600114","volume":"4","author":"N Vakil","year":"2016","unstructured":"Vakil N, Stelwagon M, Shea EP, Miller S. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United Eur Gastroenterol J 2016;4:413\u2013422.","journal-title":"United Eur Gastroenterol J"},{"key":"3850_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17474124.2023.2162877","volume":"17","author":"BE Lacy","year":"2023","unstructured":"Lacy BE, Chase RC, Cangemi DJ. The treatment of functional dyspepsia: present and future. Expert Rev Gastroenterol Hepatol 2023;17:9\u201320.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3850_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1142\/S0192415X23500398","volume":"51","author":"J Huang","year":"2023","unstructured":"Huang J, Chen T, Zhang J, Ma X, Wang F, Tang X. Overlapping symptoms of functional gastrointestinal disorders: current challenges and the role of traditional Chinese medicine. Am J Chin Med 2023;51:833\u2013857.","journal-title":"Am J Chin Med"},{"key":"3850_CR6","doi-asserted-by":"publisher","first-page":"114665","DOI":"10.1016\/j.jep.2021.114665","volume":"283","author":"L Ho","year":"2022","unstructured":"Ho L, Zhong CC, Wong CH, Wu JC, Chan KK, Wu IX, et al. Herbal medicine for functional dyspepsia: network meta-analysis of placebo-controlled randomised trials. J Ethnopharmacol 2022;283:114665.","journal-title":"J Ethnopharmacol"},{"key":"3850_CR7","doi-asserted-by":"publisher","first-page":"1130257","DOI":"10.3389\/fphar.2023.1130257","volume":"14","author":"K Kim","year":"2023","unstructured":"Kim K, Ko SJ, Cho SH, Kim J, Park JW. Herbal medicine, Banxia-Xiexin Tang, for functional dyspepsia: a systematic review and meta-analysis. Front Pharmacol 2023;14:1130257.","journal-title":"Front Pharmacol"},{"key":"3850_CR8","first-page":"44","volume":"57","author":"CH Sun","year":"2022","unstructured":"Sun CH, Tian Y, Li RM, Huo ZP, Yang ZC, Liu Y, et al. Potential pharmacological substance basis study of Lianxia Xiaopi Granules for the treatment of functional dyspepsia by UPLC-Q-TOF-MS integrated with network pharmacology. Chin Pharm J (Chin) 2022;57:44\u201351.","journal-title":"Chin Pharm J (Chin)"},{"key":"3850_CR9","doi-asserted-by":"publisher","first-page":"1334083","DOI":"10.3389\/fmolb.2023.1334083","volume":"10","author":"X Li","year":"2023","unstructured":"Li X, Dai E, Li M, Kong R, Yuan J, Li T, et al. Aurantii fructus immaturus carbonisata-derived carbon dots and their antidepression effect. Front Mol Biosci 2023;10:1334083.","journal-title":"Front Mol Biosci"},{"key":"3850_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/ph17020239","volume":"17","author":"M Qiu","year":"2024","unstructured":"Qiu M, Zhang J, Wei W, Zhang Y, Li M, Bai Y, et al. Integrated UPLC\/Q-TOF-MS\/MS analysis and network pharmacology to reveal the neuroprotective mechanisms and potential pharmacological ingredients of Aurantii Fructus Immaturus and Aurantii Fructus. Pharmaceuticals (Basel) 2024;17:239.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3850_CR11","first-page":"111","volume":"38","author":"M Gao","year":"2023","unstructured":"Gao M, Yang W. Effects of Citrus aurantium L. on gastrointestinal motility and gastric cancer cell proliferation. Cancer Biother Radiopharm 2023;38:111\u2013115.","journal-title":"Cancer Biother Radiopharm"},{"key":"3850_CR12","first-page":"51","volume":"2","author":"W Jinping","year":"2005","unstructured":"Jinping W, Jiaming B, Jie F. Pharmacodynamic study of Lianxia Xiaopi Capsule. Chin J Exp Tradit Med Formula (Chin) 2005;2:51\u201353.","journal-title":"Chin J Exp Tradit Med Formula (Chin)"},{"key":"3850_CR13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"V Stanghellini","year":"2016","unstructured":"Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal disorders. Gastroenterology 2016;150:1380\u20131392.","journal-title":"Gastroenterology"},{"key":"3850_CR14","volume-title":"Technical guidelines for clinical research of traditional Chinese medicine for irritable bowel syndrome and four other guidelines (announcement No. 217 of 2017)","author":"National Medical Products Administration","year":"2017","unstructured":"National Medical Products Administration. Technical guidelines for clinical research of traditional Chinese medicine for irritable bowel syndrome and four other guidelines (announcement No. 217 of 2017). 2017. Available from: https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ypggtg\/ypqtggtg\/20171227183101142.html (accessed July 16, 2025)."},{"key":"3850_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/ajg.2017.265","volume":"113","author":"F Taylor","year":"2018","unstructured":"Taylor F, Higgins S, Carson RT, Eremenco S, Foley C, Lacy BE, et al. Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the functional dyspepsia symptom diary (FDSD). Am J Gastroenterol 2018;113:39\u201348.","journal-title":"Am J Gastroenterol"},{"key":"3850_CR16","volume-title":"Announcement No. 44, 2023, of the Center for Drug Evaluation, National Medical Products Administration, on the Release of the \u201cTechnical Guidelines for the Design of Patient-Centred Drug Clinical Trials (Trial version)\u201d, \u201cTechnical Guidelines for the Imple","author":"Center for Drug Evaluation of the National Medical Products Administration","year":"2023","unstructured":"Center for Drug Evaluation of the National Medical Products Administration. Announcement No. 44, 2023, of the Center for Drug Evaluation, National Medical Products Administration, on the Release of the \u201cTechnical Guidelines for the Design of Patient-Centred Drug Clinical Trials (Trial version)\u201d, \u201cTechnical Guidelines for the Implementation of Patient-Centred Drug Clinical Trials (Trial version)\u201d, and \u201cTechnical Guidelines for Patient-Centred Benefit-Risk Assessment of Drugs (Trial version)\u201d. 2023. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/42c008e28f7004cd19b73949142380bd (accessed July 16, 2025)."},{"key":"3850_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/gutjnl-2019-318536","volume":"69","author":"L Wauters","year":"2020","unstructured":"Wauters L, Talley NJ, Walker MM, Tack J, Vanuytsel T. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut 2020;69:591\u2013600.","journal-title":"Gut"},{"key":"3850_CR18","first-page":"516","volume":"15","author":"B Liu","year":"2023","unstructured":"Liu B, Kou Z, Chen B. Effects and mechanisms of traditional Chinese medicines on functional dyspepsia: a review. Chin Herb Med 2023;15:516\u2013525.","journal-title":"Chin Herb Med"},{"key":"3850_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/jgh.14467","volume":"34","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Li Y, Shu J, Li Y, Xu J, Ren J, et al. The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome. J Gastroenterol Hepatol 2019;34:526\u2013531.","journal-title":"J Gastroenterol Hepatol"},{"key":"3850_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.4103\/0366-6999.235118","volume":"131","author":"Q Su","year":"2018","unstructured":"Su Q, Chen SL, Wang HH, Liang LX, Dai N, Lyu B, et al. A randomized, double-blind, multicenter, placebo-controlled trial of Qi-Zhi-Wei-Tong Granules on postprandial distress syndrome-predominant functional dyspepsia. Chin Med J (Engl) 2018;131:1549\u20131556.","journal-title":"Chin Med J (Engl)"},{"key":"3850_CR21","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.3748\/wjg.v23.i30.5589","volume":"23","author":"L Lv","year":"2017","unstructured":"Lv L, Wang FY, Ma XX, Li ZH, Huang SP, Shi ZH, et al. Efficacy and safety of Xiangsha Liujunzi Granules for functional dyspepsia: a multi-center randomized doubleblind placebo-controlled clinical study. World J Gastroenterol 2017;23:5589\u20135601.","journal-title":"World J Gastroenterol"},{"key":"3850_CR22","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.3748\/wjg.v26.i28.4170","volume":"26","author":"YD Wen","year":"2020","unstructured":"Wen YD, Lu F, Zhao YP, Wang P, Yang Q, Li JX, et al. Epigastric pain syndrome: what can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules. World J Gastroenterol 2020;26:4170\u20134181.","journal-title":"World J Gastroenterol"},{"key":"3850_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41581-022-00585-w","volume":"18","author":"A Tong","year":"2022","unstructured":"Tong A, Scholes-Robertson N, Hawley C, Viecelli AK, Carter SA, Levin A, et al. Patient-centred clinical trial design. Nat Rev Nephrol 2022;18:514\u2013523.","journal-title":"Nat Rev Nephrol"},{"key":"3850_CR24","doi-asserted-by":"publisher","first-page":"e14636","DOI":"10.1111\/nmo.14636","volume":"35","author":"L Ginton","year":"2023","unstructured":"Ginton L, Nurko S, Di Lorenzo C, Saps M. First study to assess the reliability of commonly used pain scales in children with disorders of gut-brain interaction. Neurogastroenterol Motil 2023;35:e14636.","journal-title":"Neurogastroenterol Motil"},{"key":"3850_CR25","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.14309\/ctg.0000000000000209","volume":"11","author":"L Vork","year":"2020","unstructured":"Vork L, Keszthelyi D, van Kuijk SMJ, Quetglas EG, T\u00f6rnblom H, Simr\u00e9n M, et al. Patient-specific stress-abdominal pain interaction in irritable bowel syndrome: an exploratory experience sampling method study. Clin Transl Gastroenterol 2020;11:e209.","journal-title":"Clin Transl Gastroenterol"},{"key":"3850_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/PSY.0000000000001012","volume":"84","author":"T Klaassen","year":"2022","unstructured":"Klaassen T, Vork L, Smeets FGM, Troost FJ, Kruimel JW, Leue C, et al. The interplay between stress and fullness in patients with functional dyspepsia and healthy controls: an exploratory experience sampling method study. Psychosom Med 2022;84:306\u2013312.","journal-title":"Psychosom Med"},{"key":"3850_CR27","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/jgh.15854","volume":"37","author":"X Shi","year":"2022","unstructured":"Shi X, Luo H, Wang X, Ren G, Zhang L, Tao Q, et al. Functional dyspepsia symptom diary is correlated with other questionnaires and associated with severity in patients with functional dyspepsia: a multicenter, prospective observational study. J Gastroenterol Hepatol 2022;37:1298\u20131306.","journal-title":"J Gastroenterol Hepatol"},{"key":"3850_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000532082","volume":"105","author":"T Oshima","year":"2024","unstructured":"Oshima T. Functional dyspepsia: current understanding and future perspective. Digestion 2024;105:26\u201333.","journal-title":"Digestion"},{"key":"3850_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00535-019-01550-4","volume":"54","author":"H Miwa","year":"2019","unstructured":"Miwa H, Oshima T, Tomita T, Fukui H, Kondo T, Yamasaki T, et al. Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center. J Gastroenterol 2019;54:305\u2013311.","journal-title":"J Gastroenterol"},{"key":"3850_CR30","doi-asserted-by":"publisher","first-page":"13947","DOI":"10.3390\/ijms232213947","volume":"23","author":"T Okata","year":"2022","unstructured":"Okata T, Asanuma K, Nakagawa K, Hatta W, Koike T, Imatani A, et al. The impact of duodenal mucosal vulnerability in the development of epigastric pain syndrome in functional dyspepsia. Int J Mol Sci 2022;23:13947.","journal-title":"Int J Mol Sci"},{"key":"3850_CR31","doi-asserted-by":"publisher","first-page":"115085","DOI":"10.1016\/j.jep.2022.115085","volume":"291","author":"W Wang","year":"2022","unstructured":"Wang W, Gu W, He C, Zhang T, Shen Y, Pu Y. Bioactive components of Banxia Xiexin Decoction for the treatment of gastrointestinal diseases based on flavor-oriented analysis. J Ethnopharmacol 2022;291:115085.","journal-title":"J Ethnopharmacol"},{"key":"3850_CR32","doi-asserted-by":"publisher","first-page":"698887","DOI":"10.3389\/fphar.2021.698887","volume":"12","author":"YH Kim","year":"2021","unstructured":"Kim YH, Kim JY, Kwon OJ, Jung SY, Joung JY, Yang CS, et al. Efficacy of a traditional herbal formula, Banha-Sasim-Tang in functional dyspepsia classified as excess pattern. Front Pharmacol 2021;12:698887.","journal-title":"Front Pharmacol"},{"key":"3850_CR33","first-page":"956","volume":"40","author":"Q Geng","year":"2025","unstructured":"Geng Q, Li JW, Ling JH, Jiang J. Banxia Xiexin Decoction in the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled study. China J Tradit Chin Med Pharm (Chin) 2025;40:956\u2013961.","journal-title":"China J Tradit Chin Med Pharm (Chin)"},{"key":"3850_CR34","doi-asserted-by":"publisher","first-page":"114366","DOI":"10.1016\/j.jep.2021.114366","volume":"279","author":"R Qiao","year":"2021","unstructured":"Qiao R, Zhou L, Zhong M, Zhang M, Yang L, Yang Y, et al. Spectrum-effect relationship between UHPLC-Q-TOF\/MS fingerprint and promoting gastrointestinal motility activity of Fructus Aurantii based on multivariate statistical analysis. J Ethnopharmacol 2021;279:114366.","journal-title":"J Ethnopharmacol"},{"key":"3850_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopha.2017.03.060","volume":"90","author":"W Tan","year":"2017","unstructured":"Tan W, Li Y, Wang Y, Zhang Z, Wang T, Zhou Q, et al. Anti-coagulative and gastrointestinal motility regulative activities of Fructus Aurantii Immaturus and its effective fractions. Biomed Pharmacother 2017;90:244\u2013252.","journal-title":"Biomed Pharmacother"},{"key":"3850_CR36","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1007\/s12035-024-03958-3","volume":"61","author":"Y Wen","year":"2024","unstructured":"Wen Y, Zhan Y, Chen T, Li J, Long Q, Zheng F, et al. Total flavonoids of Aurantii Fructus Immaturus regulate mir-5100 to improve constipation by targeting fzd2 to alleviate calcium balance and autophagy in interstitial cells of Cajal. Mol Neurobiol 2024;61:5882\u20135900.","journal-title":"Mol Neurobiol"},{"key":"3850_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5056\/jnm17066","volume":"23","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Chung WC, Kim BW, Kim SS, Kim JI, Kim NJ, et al. Is Helicobacter pylori associated functional dyspepsia correlated with dysbiosis? J Neurogastroenterol Motil 2017;23:504\u2013516.","journal-title":"J Neurogastroenterol Motil"},{"key":"3850_CR38","doi-asserted-by":"publisher","first-page":"e13719","DOI":"10.1111\/nmo.13719","volume":"32","author":"R Ji","year":"2020","unstructured":"Ji R, Wang P, Kou GJ, Zuo XL, Wang X, Li YQ. Impaired gastric mucosal integrity identified by confocal endomicroscopy in Helicobacter pylori-negative functional dyspepsia. Neurogastroenterol Motil 2020;32:e13719.","journal-title":"Neurogastroenterol Motil"},{"key":"3850_CR39","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1038\/s41598-018-23620-y","volume":"8","author":"H Vanheel","year":"2018","unstructured":"Vanheel H, Vicario M, Boesmans W, Vanuytsel T, Salvo-Romero E, Tack J, et al. Activation of eosinophils and mast cells in functional dyspepsia: an ultrastructural evaluation. Sci Rep 2018;8:5383.","journal-title":"Sci Rep"},{"key":"3850_CR40","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.cgh.2022.01.014","volume":"20","author":"A Shah","year":"2022","unstructured":"Shah A, Fairlie T, Brown G, Jones MP, Eslick GD, Duncanson K, et al. Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies. Clin Gastroenterol Hepatol 2022;20:2229\u20132242.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3850_CR41","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/gutjnl-2020-320633","volume":"72","author":"T Vanuytsel","year":"2023","unstructured":"Vanuytsel T, Bercik P, Boeckxstaens G. Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders. Gut 2023;72:787\u2013798.","journal-title":"Gut"},{"key":"3850_CR42","doi-asserted-by":"publisher","first-page":"101637","DOI":"10.1016\/j.bpg.2019.101637","volume":"40\u201341","author":"L Koletzko","year":"2019","unstructured":"Koletzko L, Macke L, Schulz C, Malfertheiner P. Helicobacter pylori eradication in dyspepsia: new evidence for symptomatic benefit. Best Pract Res Clin Gastroenterol 2019;40\u201341:101637.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"3850_CR43","doi-asserted-by":"publisher","first-page":"2438735","DOI":"10.1080\/21505594.2024.2438735","volume":"16","author":"M Clyne","year":"2025","unstructured":"Clyne M, \u00d3 Cr\u00f3in\u00edn T. Pathogenicity and virulence of Helicobacter pylori: a paradigm of chronic infection. Virulence 2025;16:2438735.","journal-title":"Virulence"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-3850-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-3850-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-3850-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:47:16Z","timestamp":1784987236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-3850-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-3850-4","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"29 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}